PAX Labs
Date | Investors | Amount | Round |
---|---|---|---|
$46.7m | Series C | ||
N/A | Secondary | ||
N/A | $55.0m | Early VC | |
$20.0m | Early VC | ||
$420m Valuation: $1.3b | Growth Equity VC | ||
Total Funding | €492m |
Related Content
Recent News about PAX Labs
EditPax Labs, Inc. specializes in the design and manufacturing of high-quality cannabis vaporizers and accessories, catering to both recreational and medicinal cannabis users. Operating primarily in the North American and European markets, Pax Labs offers a range of products including the PAX Era and PAX 3 vaporizers, which are known for their sleek design, advanced temperature control, and user-friendly interface. The company’s business model revolves around direct-to-consumer sales through its website and partnerships with licensed dispensaries, generating revenue from both device sales and complementary accessories. Pax Labs aims to enhance the cannabis consumption experience by providing reliable, easy-to-use products that offer precise control over dosage and flavor. The company serves a diverse clientele, from casual users to cannabis connoisseurs, and leverages technology to ensure a consistent and enjoyable experience.
Keywords: cannabis, vaporizers, accessories, PAX Era, PAX 3, temperature control, user-friendly, direct-to-consumer, dispensaries, technology.